Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2)

Catalog #:   RVV15302 Specific References (55) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, IF
Accession: P03211
Overview

Catalog No.

RVV15302

Species reactivity

Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Epstein-Barr nuclear antigen 1, EBNA-1, EBV nuclear antigen 1, EBNA1, BKRF1

Concentration

2.46 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03211

Applications

ELISA, IF

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

16D2

Data Image
  • SDS-PAGE
    SDS PAGE for EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2)
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References

Mapping an epitope in EBNA-1 that is recognized by monoclonal antibodies to EBNA-1 that cross-react with dsDNA. PMID: 27621818

Characterization of neutralizing monoclonal antibody escape mutants of Hantaan virus 76118. PMID: 9505967

SRLS analysis of 15N spin relaxation from E. coli ribonuclease HI: the tensorial perspective. PMID: 22126306

SYNTHESIS OF SOME STEROIDAL (3,2-D)- AND (17,16-D)-2',6'DIAMINOPYRIMIDINES. PMID: 14185998

Preparation of specifically dideuterated octadecanoates and oxooctadecanoates. PMID: 834126

Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors., PMID:40459582

Virus-specific antibody responses in multiple sclerosis patients treated with Ocrevus., PMID:40398376

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta., PMID:40372913

Paediatric autoimmune uveitis is associated with intraocular antibodies against Epstein-Barr virus Nuclear Antigen 1 (EBNA-1)., PMID:40239467

Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)., PMID:40214827

Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals., PMID:40157431

Strong association with remote EBV infection in children with MS as opposed to other acquired demyelinating disorders., PMID:40102037

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls., PMID:40063790

A Bidirectional Mendelian Randomization Study on the Causal Relationship Between Epstein-Barr Virus Antibodies and Prostate Cancer Risk., PMID:40026212

SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis., PMID:40016549

Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk., PMID:39984542

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest., PMID:39879169

Exploring bidirectional causal relationships between antibody-mediated immune responses to infectious agents and systemic lupus erythematosus through Mendelian randomization and meta-analyses., PMID:39863087

EBV-specific T-cell immunity: relevance for multiple sclerosis., PMID:39776919

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha crystalline beta., PMID:39763959

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis., PMID:39742283

Epstein-Barr virus infection in patients with MOGAD., PMID:39668776

Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis., PMID:39666032

Epstein-Barr nuclear antigen 1 antibody-based indices are increased in patients with multiple sclerosis., PMID:39577298

Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation., PMID:39514105

Does Epstein-Barr virus and intracellular Toll-like receptors affect the course of Hashimoto disease? Findings from studies on newly-diagnosed patients., PMID:39508448

Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease., PMID:39472059

Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient., PMID:39427375

Greater humoral EBV response may be associated with choroid plexus inflammation in progressive MS., PMID:39420132

Structure-based design of antibodies targeting the EBNA1 DNA-binding domain to block Epstein-Barr virus latent infection and tumor growth., PMID:39399647

TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice., PMID:39387189

Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection., PMID:39380297

EBNA-1 antibody and autoimmune rheumatic diseases: A Mendelian Randomization Study., PMID:39286141

The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction., PMID:39264275

Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis., PMID:39257578

The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis., PMID:39244576

Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder., PMID:39046523

Analysis of the Association Between Pathogen Exposure and the Risk of Dementia., PMID:38995782

Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy., PMID:38921797

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression., PMID:38911861

Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma., PMID:38894502

Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study., PMID:38860471

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis., PMID:38843296

Alzheimer's disease risk associated with changes in Epstein-Barr virus nuclear antigen 1-specific epitope targeting antibody levels., PMID:38824738

EBV and multiple sclerosis: expression of LMP2A in MS patients., PMID:38721048

Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis., PMID:38630618

Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides., PMID:38547427

Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis., PMID:38497939

The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease., PMID:38472667

Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review., PMID:38401201

Antibody Profiling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis., PMID:38309569

The Relationship between Cancer Stage, Selected Immunological Parameters, Epstein-Barr Virus Infection, and Total Serum Content of Iron, Zinc, and Copper in Patients with Laryngeal Cancer., PMID:38256645

Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830

Can the Epstein-Barr Virus Play a Role in the Development of Prostate Cancer?, PMID:38254816

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2) [RVV15302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only